Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000031.xml
Klin Monbl Augenheilkd 2024; 241(04): 385-387
DOI: 10.1055/a-2215-8715
DOI: 10.1055/a-2215-8715
Der interessante Fall
New-Onset Bilateral Corneal Opacity of Unknown Origin – A Case Report
Neu aufgetretene bilaterale Hornhauttrübung unbekannter Ursache – ein Fallbericht
Background
Corneal opacities represent a leading cause of blindness worldwide [1]. As shown by Hashemi et al. in patients above 60 years of age, the prevalence of corneal opacities in at least one eye is 9.58% [2].
Publication History
Received: 29 October 2023
Accepted: 17 November 2023
Article published online:
23 April 2024
© 2024. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Wang EY, Kong X, Wolle M. et al. Global Trends in Blindness and Vision Impairment Resulting from Corneal Opacity 1984–2020: A Meta-analysis. Ophthalmology 2023; 130: 863-871 DOI: 10.1016/j.ophtha.2023.03.012.
- 2 Hashemi H, Pakzad R, Aghamirsalim M. et al. Age and Sex Standardized Prevalence of Corneal Opacity and Its Determinants; Tehran Geriatric Eye Study (TGES). Iran J Public Health 2022; 51: 643 DOI: 10.18502/IJPH.V51I3.8941.
- 3 Wadhera RK, Rajkumar SV. Prevalence of monoclonal gammopathy of undetermined significance: a systematic review. Mayo Clin Proc 2010; 85: 933 DOI: 10.4065/MCP.2010.0337.
- 4 Kyle RA, Therneau TM, Rajkumar SV. et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002; 346: 564-569 DOI: 10.1056/NEJMOA01133202.
- 5 Garibaldi DC, Gottsch J, de la Cruz Z. et al. Immunotactoid keratopathy: a clinicopathologic case report and a review of reports of corneal involvement in systemic paraproteinemias. Surv Ophthalmol 2005; 50: 61-80 DOI: 10.1016/J.SURVOPHTHAL.2004.10.002.
- 6 Landgren O, Kyle RA, Pfeiffer RM. et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 2009; 113: 5412 DOI: 10.1182/BLOOD-2008-12-194241.
- 7 Ríos-Tamayo R, Paiva B, Lahuerta JJ. et al. Monoclonal Gammopathies of Clinical Significance: A Critical Appraisal. Cancers (Basel) 2022; 14: 5247 DOI: 10.3390/CANCERS14215247.
- 8 Ormerod LD, Collin HB, Dohlman CH. et al. Paraproteinemic crystalline keratopathy. Ophthalmology 1988; 95: 202-212 DOI: 10.1016/S0161-6420(88)33200-8.
- 9 Klintworth GK, Bredehoeft SJ, Reed JW. Analysis of corneal crystalline deposits in multiple myeloma. Am J Ophthalmol 1978; 86: 303-313 DOI: 10.1016/0002-9394(78)90230-1.
- 10 Bourne WM, Kyle RA, Brubaker RF. et al. Incidence of corneal crystals in the monoclonal gammopathies. Am J Ophthalmol 1989; 107: 192-193 DOI: 10.1016/0002-9394(89)90225-0.
- 11 Lisch W, Saikia P, Pitz S. et al. Chameleon-like appearance of immunotactoid keratopathy. Cornea 2012; 31: 55-58 DOI: 10.1097/ICO.0B013E31821DDD0C.
- 12 Nobacht S, Kusters B, Breukink MB. et al. Recurrence of paraproteinemic crystalline keratopathy after corneal transplantation: A case of monoclonal gammopathy of ocular significance. Am J Ophthalmol Case Rep 2020; 19: 100803 DOI: 10.1016/j.ajoc.2020.100803.
- 13 Milman T, Kao AA, Chu D. et al. Paraproteinemic Keratopathy. Ophthalmology 2015; 122: 1748-1756 DOI: 10.1016/j.ophtha.2015.05.029.